Discovery Finalizing Surfaxin “Complete Response,” Eyes 2008 Approval
This article was originally published in The Pink Sheet Daily
Executive Summary
Firm plans response to May 1 “approvable” letter that addresses biological activity test criteria, lipid-related impurities.